Jacques Clémenty

Author PubWeight™ 117.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008 8.26
2 Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004 4.99
3 Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008 4.43
4 Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002 3.69
5 Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol 2005 3.58
6 Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005 3.46
7 Technique and results of linear ablation at the mitral isthmus. Circulation 2004 2.74
8 Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004 2.63
9 Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003 2.56
10 Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol 2008 2.50
11 Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2002 2.36
12 Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 2009 2.21
13 Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm 2010 2.19
14 Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J 2005 2.14
15 High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm 2006 2.10
16 Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J 2008 1.98
17 A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2012 1.91
18 A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol 2008 1.81
19 Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 2005 1.75
20 Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002 1.66
21 Organization of frequency spectra of atrial fibrillation: relevance to radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006 1.65
22 Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 2006 1.63
23 Dissociated pulmonary vein arrhythmia: incidence and characteristics. J Cardiovasc Electrophysiol 2003 1.63
24 Are women with severely symptomatic brugada syndrome different from men? J Cardiovasc Electrophysiol 2008 1.62
25 Atrial fibrillation originating from persistent left superior vena cava. Circulation 2004 1.60
26 Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol 2006 1.58
27 Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J 2007 1.53
28 Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm 2004 1.52
29 Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 2009 1.46
30 Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006 1.46
31 High-resolution mapping of tachycardia originating from the superior vena cava: evidence of electrical heterogeneity, slow conduction, and possible circus movement reentry. J Cardiovasc Electrophysiol 2002 1.45
32 Electrophysiologically guided pulmonary vein isolation during sustained atrial fibrillation. J Cardiovasc Electrophysiol 2003 1.45
33 Mitral isthmus ablation with and without temporary spot occlusion of the coronary sinus: a randomized clinical comparison of acute outcomes. J Cardiovasc Electrophysiol 2012 1.40
34 Unexpected ventricular asystole in a DDD pacemaker: what is the mechanism? Pacing Clin Electrophysiol 2002 1.39
35 Tachycardia transition during ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2010 1.38
36 Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008 1.37
37 Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002 1.34
38 Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 2003 1.32
39 Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2004 1.32
40 The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect. J Interv Card Electrophysiol 2006 1.30
41 Automatic home monitoring of implantable cardioverter defibrillators. Europace 2008 1.21
42 Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace 2008 1.20
43 Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2010 1.18
44 Characterization of focal atrial tachycardia using high-density mapping. J Am Coll Cardiol 2005 1.14
45 Catheter ablation for atrial fibrillation. Circulation 2007 1.10
46 Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome. Eur Heart J 2007 1.08
47 Inhibition of biventricular pacemakers by oversensing of far-field atrial depolarization. Pacing Clin Electrophysiol 2002 1.07
48 Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol 2005 1.05
49 A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol 2008 1.05
50 High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007 1.03
51 How to perform linear lesions. Heart Rhythm 2007 1.01
52 Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol 2007 1.00
53 Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm 2012 0.98
54 Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm 2011 0.97
55 Impact of catheter ablation of the coronary sinus on paroxysmal or persistent atrial fibrillation. J Cardiovasc Electrophysiol 2007 0.97
56 Impact of pharmacological autonomic blockade on complex fractionated atrial electrograms. J Cardiovasc Electrophysiol 2010 0.97
57 Pulmonary veins in the substrate for atrial fibrillation: the "venous wave" hypothesis. J Am Coll Cardiol 2004 0.96
58 Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts. J Cardiovasc Electrophysiol 2004 0.95
59 Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation. Heart Rhythm 2005 0.94
60 Characterization of conduction recovery across left atrial linear lesions in patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 2006 0.94
61 Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace 2009 0.93
62 Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc Res 2002 0.92
63 Contributions of advanced techniques to the success and safety of transvenous leads extraction. Pacing Clin Electrophysiol 2009 0.92
64 Electrogram polarity reversal as an additional indicator of breakthroughs from the left atrium to the pulmonary veins. J Am Coll Cardiol 2002 0.91
65 An approach to catheter ablation of cavotricuspid isthmus dependent atrial flutter. Indian Pacing Electrophysiol J 2006 0.91
66 Pulmonary vein disconnection using the LocaLisa three-dimensional nonfluoroscopic catheter imaging system. J Cardiovasc Electrophysiol 2003 0.90
67 Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 2009 0.89
68 Flutter localized to the anterior left atrium after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006 0.89
69 Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2003 0.88
70 Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol 2005 0.88
71 Focal arrhythmia confined within the coronary sinus and maintaining atrial fibrillation. J Cardiovasc Electrophysiol 2007 0.88
72 Sites of focal atrial activity characterized by endocardial mapping during atrial fibrillation. J Am Coll Cardiol 2006 0.87
73 Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study. Europace 2011 0.87
74 Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol 2014 0.86
75 Radiofrequency puncture of the fossa ovalis for resistant transseptal access. Circ Arrhythm Electrophysiol 2008 0.86
76 Shortening of fibrillatory cycle length in the pulmonary vein during vagal excitation. J Am Coll Cardiol 2006 0.85
77 Dilatation as a marker of pulmonary veins initiating atrial fibrillation. J Interv Card Electrophysiol 2002 0.83
78 How to interpret and identify pulmonary vein recordings with the lasso catheter. Heart Rhythm 2006 0.81
79 High-density circumferential pulmonary vein mapping with a 20-pole expandable circular mapping catheter. Pacing Clin Electrophysiol 2005 0.81
80 Relationship between perimitral and peritricuspid conduction times. Heart Rhythm 2007 0.80
81 Mitral isthmus ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2005 0.78
82 Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view. Europace 2008 0.77
83 Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study. Am Heart J 2008 0.77
84 Myocardial pacing lead perforation revealed by mammary hematoma next to the device pocket. J Cardiovasc Electrophysiol 2007 0.77
85 Catheter ablation of persistent and permanent atrial fibrillation: Bordeaux experience. Expert Rev Cardiovasc Ther 2007 0.77
86 Fluctuation of atrial and ventricular lead impedances heralding subtotal separation of device header and generator in a patient with an implantable cardioverter-defibrillator. Heart Rhythm 2006 0.77
87 Left atrial linear ablation to modify the substrate of atrial fibrillation using a new nonfluoroscopic imaging system. Pacing Clin Electrophysiol 2005 0.75
88 Fibrillating areas isolated within the left atrium after radiofrequency linear catheter ablation. J Cardiovasc Electrophysiol 2006 0.75
89 Atypical left atrial flutters. Card Electrophysiol Rev 2002 0.75
90 Far-field P-wave sensing by the right ventricular lead of conventional dual chamber pacemakers. J Interv Card Electrophysiol 2002 0.75
91 [Ablative methods for atrial fibrillation]. Rev Prat 2002 0.75
92 Cycle length dependent block in the "mitral-pulmonary vein" isthmus. Pacing Clin Electrophysiol 2007 0.75
93 Double jeopardy in an implantable cardioverter defibrillator patient. J Cardiovasc Electrophysiol 2003 0.75
94 Atrial arrhythmia after a first atrial fibrillation ablation: what is the mechanism? J Cardiovasc Electrophysiol 2007 0.75
95 Left atrial "mitral isthmus" block after radiofrequency ablation? J Cardiovasc Electrophysiol 2007 0.75
96 An approach to noncavotricuspid isthmus dependent flutter. J Cardiovasc Electrophysiol 2005 0.75